KetaMD Inc.

Braxia Scientific Corp. (OTC Pink: BRAXF), owner of ketamine therapy clinics and KetaMD telemedicine services for depression and related disorders, has shared its interim financial statements for the three months ended June 30, 2023.  In numbers:  Cash held was $636.483 (CA$861,393) as...

A researcher and provider of ketamine-assisted treatments for mental health conditions, Braxia Scientific Corp. (OTC: BRAXF) has completed the acquisition of the issued and outstanding stock of U.S.-based, private telemedicine company KetaMD Inc., with the goal of addressing mental health issues by...